Alaunos Therapeutics, Inc. (TCRT) insider trading.
In Q3 2026, insiders at Alaunos Therapeutics, Inc. reported 6 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 4
- Last filed
- 2026-08-11
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Weis Holger | Officer · CEO | 3 | 0 | 0 |
| Vieser Jaime | Director | 1 | 0 | 0 |
| Postma Robert W | Director | 1 | 0 | 0 |
| Jerman Michael Allen | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Weis Holger | A (A) | 4,363 | $2.01 | 25,483 | Form 4 |
| 2026-07-23 | Vieser Jaime | A (A) | 8,789 | $1.92 | 47,642 | Form 4 |
| 2026-07-23 | Postma Robert W | A (A) | 8,463 | $1.92 | 58,609 | Form 4 |
| 2026-07-23 | Weis Holger | A (A) | 4,568 | $1.92 | 21,120 | Form 4 |
| 2026-07-23 | Jerman Michael Allen | A (A) | 8,138 | $1.92 | 23,759 | Form 4 |
| 2026-06-30 | Weis Holger | A (A) | 3,880 | $2.26 | 16,552 | Form 4 |
Transaction codes in this quarter
Get TCRT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1107421&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · TCRT company page · Alaunos Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Alaunos Therapeutics, Inc. (TCRT)?
In Q3 2026, insiders at Alaunos Therapeutics, Inc. reported 6 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Alaunos Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/tcrt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.